BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35259419)

  • 1. Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis.
    Hande V; Chopra S; Kalra B; Abdel-Wahab M; Kannan S; Tanderup K; Grover S; Zubizarreta E; Rubio JAP
    Radiother Oncol; 2022 May; 170():70-78. PubMed ID: 35259419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
    Mayadev J; Viswanathan A; Liu Y; Li CS; Albuquerque K; Damato AL; Beriwal S; Erickson B
    Brachytherapy; 2017; 16(1):22-43. PubMed ID: 28109631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.
    Petit A; Floquet A; Lasbareilles O; Stoeckle E; Chemin A; Kind M; Guyon F; Brouste V; Pigneux J; Thomas L
    Brachytherapy; 2013; 12(6):542-9. PubMed ID: 23880416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
    Refaat T; Donnelly ED; Gentile M; Novak C; Yuan Y; Khedr GA; Helenowksi I; Lurain J; Schink J; Rademaker A; Sathiaseelan V; Strauss JB; Small W
    Am J Clin Oncol; 2016 Apr; 39(2):196-203. PubMed ID: 24487420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
    [No Abstract]   [Full Text] [Related]  

  • 7. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
    Cho LP; Manuel M; Catalano P; Lee L; Damato AL; Cormack RA; Buzurovic I; Bhagwat M; O'Farrell D; Devlin PM; Viswanathan AN
    Gynecol Oncol; 2016 Dec; 143(3):545-551. PubMed ID: 27720445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review and meta-analysis.
    Kim YJ; Kang HC; Kim YS
    Strahlenther Onkol; 2020 Nov; 196(11):973-982. PubMed ID: 32632466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
    D'Cunha P; Gonzalez Y; Nwachukwu C; Hrycushko B; Medin P; Owrangi A; Jia X; Albuquerque K
    Brachytherapy; 2022; 21(5):668-677. PubMed ID: 35871130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of high-dose-rate interstitial brachytherapy in the treatment of locally advanced cervical cancer: long-term results.
    Pinn-Bingham M; Puthawala AA; Syed AM; Sharma A; Disaia P; Berman M; Tewari KS; Randall-Whitis L; Mahmood U; Ramsinghani N; Kuo J; Chen WP; McLaren CE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):714-20. PubMed ID: 22763030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 3D image-guided brachytherapy compared to 2D conventional brachytherapy on clinical outcomes in patients with cervical cancer: A systematic review and meta-analyses.
    Suzumura EA; Gama LM; Jahn B; Campolina AG; Carvalho HA; de Soárez PC
    Brachytherapy; 2021; 20(4):710-737. PubMed ID: 33867297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.
    Refaat T; Castelain B; Small W; Elsaid A; Lotfy N; Lartigau E; Nickers P
    Am J Clin Oncol; 2015 Jun; 38(3):289-93. PubMed ID: 23799285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
    Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.